Krystal Biotech
KRYS
KRYS
280 hedge funds and large institutions have $5.1B invested in Krystal Biotech in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 106 increasing their positions, 89 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
280
Holders Change
+36
Holders Change %
+14.75%
% of All Funds
4.05%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
53
Increased
106
Reduced
89
Closed
16
Calls
$89.7M
Puts
$67.2M
Net Calls
+$22.6M
Net Calls Change
+$10.3M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$34.4M |
| 2 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$22.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$21.8M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$16.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$16.5M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$38.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.5M |
| 3 |
Goldman Sachs
New York
|
-$22M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$20.4M |
| 5 |
Jennison Associates
New York
|
-$20.1M |
